Topical Application of Imiquimod Gel at Different Concentrations in Actinic Cheilitis

NCT04219358 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

49

Enrollment

OTHER

Sponsor class

Stopped Study terminated because of COVID19 pandemics.

Conditions

Actinic Cheilitis

Interventions

DRUG: Vehicle Gel Base
DRUG: Imiquimod 5% gel
DRUG: Imiquimod 0,05% gel
DRUG: Imiquimod nanoencapsulated 0,05% gel
DRUG: Lip sunscreen 30 Sun Protector Factor (SPF)
DRUG: Dexpanthenol

Sponsor

Hospital de Clinicas de Porto Alegre

Collaborators

[object Object]